In Latin America and the Caribbean there is now recognition that the economic dimensions of health interventions, such as cost-effectiveness and budget impact, are critical dimensions that should always be taken into account when making decisions about the coverage or inclusion of technologies in benefit packages. However, there are barriers and limitations that prevent the evaluation of economic evidence in the region from being an integral part of decision-making processes. This webinar and the Technical Note that we launched provide elements and tools to contribute, in a practical way, to overcome the barriers that the application of economic evidence faces. We answer the questions asked by health systems that are beginning to apply it.
Use of economic evidence in public health decision making
Oct 06, 2021
Presentado por:
Michael Drummond, Andrés Pichon-Rivière, Santiago Torales, Vania Canuto, Adriana Robayo
Archivos adicionales